Abstract
The diagnosis of rheumatoid arthritis (RA) is initially based on clinical manifestations. Serological support for such a diagnosis is not very well established and depends mainly on the presence of rheumatoid factors (RF). A positive RF test has a predictive value [1] and is related to disease with a more severe outcome [2]. However, RF is also present in other (autoimmune) diseases and in control sera from healthy people [3]. Therefore, testing for a second RA-specific antibody is very useful, especially for the management of seronegative RA patients. Both the antiperinuclear factor (APF) (reviewed in [4]) and antikeratin antibodies (AKA) (reviewed in [4] and [5]) are helpful in this respect.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- APF:
-
antiperinuclear factor
- AKA:
-
antikeratin antibody
- RA:
-
rheumatoid arthritis
- RF:
-
rheumatoid factor
- WHO:
-
World Health Organization
References
Valkenburg HA, Ball J, Burch TA et al.(1966) Rheumatoid factors in a rural population. Ann Rheum Dis 25: 497–508
Kellgren JH, O’Brien WH (1962) On the natural history of rheumatoid arthritis in relation to sheep cell agglutination test (SCAT). Arthr Rheum 5: 115
Waller MV, Toone EC, Vaughan E (1964) Study of rheumatoid factor in a normal population. Arthr Rheum 7: 513–520
Hoet RMA, van Venrooij WJ (1992) The antiperinuclear factor (APF) and antikeratin antibodies (AKA) in rheumatoid arthritis. In Smolen JS, Kalden JR, Maini RN (Eds) Rheumatoid Arthritis, Recent Research Advances (pp. 299–327). Springer Verlag Berlin Heidelberg New York
Vincent C, Serre G, Lapeyre F, Fournié B, Ayrolles C, Fournié A, Soleilhavoup J-P (1989) High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called “antikeratin antibodies”. Ann Rheum Dis 48: 712–722
Nienhuis RLF, Mandema E (1964) A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis 23: 302–305
Smit JW, Sondag-Tschroots IRJM, Aaij C, Feltkamp TEW, Feltkamp-Vroom TM (1980) The antiperinuclear factor. II. A light-microscopical and immunofluorescence study on the antigenic substrate. Ann Rheum Dis 39: 381–386
Hoet RMA, Arends M, Boerbooms AMTh, Ruiter DJ, van Venrooij WJ (1991) Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis. Colocalisation of the perinuclear factor and profilaggrin. Ann Rheum Dis 50: 611–619
Visconti A, Cava L, Fontana G (1964) Ricerca del fattore anti-perinucleare (APF) nell’ artrite reumatoide ed in altre malattie. Osp Magg 59: 1357
Marmont AM, Damasio EE, Bertorello C, Rossi F (1967) Studies on the antiperinuclear factor. Arthr Rheum 10: 117–128
Roques MT (1969) Les anticorps dits périnucléaires. Thesis, Paris
Sondag-Tschroots IRJM, Aaij C, Smit JW, Feltkamp TEW (1979) The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Ann Rheum Dis 38: 248–251
Johnson GD, Carvalho A, Holborow EJ, Goddard DH, Russell G (1981) Antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. Ann Rheum Dis 40: 263–266
Cassani F, Ferri S, Bianchi FB, Zauli D, Pisi E (1983) Antiperinuclear factor in an Italian series of patients with rheumatoid arthritis. Ric Clin Lab 13: 347–352
Youinou P, Le Goff P, Miossec P (1983) Untersuchungen zur beziehung zwischen antiperinucleären factoren, anti-keratin-antikörpern und dem agglutinierenden und nicht agglutinierenden rheumafactor bei der chronischen polyarthritis. Z Rheumatol 42: 36–39
Kataaha PK, Mortazavi-Milani SM, Russel G, Holborow EJ (1985) Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis. Ann Rheum Dis 44: 446–449
Westgeest AAA, Boerbooms AMTh, Jongmans M, Vandenbroucke JP, Vierwinden G, van de Putte LBA (1987) Antiperinuclear factor: Indicator of more severe disease in seronegative rheumatoid arthritis. J Rheumatol 14: 893–897
Janssens X, Veys EM, Verbruggen G, Declercq L (1988) The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. J Rheumatol 15: 1346–1350
Vivino FB, Maul GG (1990) Histologic and electron microscopic characterization of the perinuclear factor antigen. Arthr Rheum 33: 960–969
Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ (1979) Anti-keratin antibodies in rheumatoid arthritis. Br Med J ii: 97–99
Scott DL, Delamere JP, Jones LJ, Walton KW (1981) Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis. Ann Rheum Dis 40: 267–271
Ordeig J, Guardia J (1984) Diagnostic value of antikeratin antibodies in rheumatoid arthritis. J Rheumatol 11: 602–604
Hajiroussou VJ, Skingle J, Gillett AP, Webley M (1985) Significance of antikeratin antibodies in rheumatoid arthritis. J Rheumatol 12: 57–59
Mallya RK, Young BJJ, Pepys MB, Hamblin TJ, Mace BEW, Hamilton EBD (1983) Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease. Clin Exp Immunol 51: 17–20
Kirnstein H, Mathiesen FK (1987) Antikeratin antibodies in rheumatoid arthritis. Scand J Rheumatology 16: 331–337
Youinou P, Le Goff P, Colaco CB, Thivolet J, Tater D, Viac J, Shipley M (1985) Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis 44: 450–454
Meyer O, Fabregas D, Cyna L, Ryckewaert A (1986) Les anticorps anti-kératine. Un marqueur des polyarthrites rhumatoïdes évolutives. Rev Rhum Mal Osteoartic 53: 601–605
Quismorio PF, Kaufman RL, Beardmore T, Mongan ES (1983) Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis. Arthritis Rheum 26: 494–499
Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M (1992) Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis 51: 743–746
Miossec P, Youinou P, Le Goff P, Moineau MP (1982) Clinical relevance of antikeratin antibodies in rheumatoid arthritis. Clin Rheumatol 1: 185–189
Anderson SAG, Bentzon MW, Houba V, Krag P (1970) International reference preparation of rheumatoid arthritis serum. Bull. Wld Hlth Org 42: 311–318
Westgeest AAA, Boerbooms AMTh, van de Putte LBA (1990) The influence of serumdilution on finding of antiperinuclear factor prevalence in rheumatoid arthritis. Arthr Rheum 33: 759–760
Feltkamp TEW, Boerbooms AMTh, De Keyser F, Dumais M, Hoet RM, van Venrooij WJ, Verbruggen G, Veys EM, Youinou P (1990) Antiperinuclear factor — standardization program. Clin Rheumatol 9: 112–113
Feltkamp TEW, Boerbooms AMTH, Geertzen HGM, Hoet RMA, De Keyser F, van Venrooij WJ, Verbruggen G, Veys EM, Youinou P (1993) Interlaboratory variability of the antiperinuclear factor (APF) test for rheumatoid arthritis. Clin Rheumatol 11: 57–59
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hoet, R.M.A. (1993). Detection of antiperinuclear factor and antikeratin antibodies. In: Van Venrooij, W.J., Maini, R.N. (eds) Manual of Biological Markers of Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5444-4_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-5444-4_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-4243-4
Online ISBN: 978-94-011-5444-4
eBook Packages: Springer Book Archive